Home » COVANCE ACQUIRES SIGNET LABORATORIES
COVANCE ACQUIRES SIGNET LABORATORIES
Covance Inc. has announced that it has acquired substantially all of the assets of Signet Laboratories, Inc. for $8.95 million. "This acquisition strengthens Covance's leadership position in providing antibodies and detection reagents that support early drug development discovery work," said Joe Herring, Covance Chairman and CEO.
Genomics & Proteomics (http://www.genomicsproteomics.com/index.aspx?ID=72802)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May